Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Current approaches to neurosurgical treatment for drug-resistant focal epilepsy in adults

https://doi.org/10.14412/2074-2711-2018-1S-81-88

Full Text:

Abstract

The review is dedicated to the problems of current neurosurgical treatment for drug-resistant epilepsy in the adult population of Russia and foreign countries. The literature published in the period  2010–2017 was sought in Russian and foreign databases. This  review included 58 only full-text publications. The search results  have shown that despite advances in neurosurgery for drug-resistant epilepsy and the development of new surgical procedures, the  problem of this disease has not yet been fully resolved today. This is  evidenced by fairly high global prevalence rates in patients with  postoperative epilepsy resistant to antiepileptic therapy. The  literature analysis has revealed that the mean prevalence of postoperative epilepsy is 69%. This indicator may vary according  to the type of an epileptogenic structural lesion and its location in  the brain. However, despite the rapid development of epilepsy  surgery, currently there is still a low surgical activity in the treatment  of patients with drugresistant epilepsy. Of importance is  also the presence of postoperative complications, including various  infectious complications and neurological deficit. Taking into account  the high rate of postoperative epilepsy, it is concluded that it is  appropriate to develop postoperative rehabilitation methods for patients with drug-resistant epilepsy.

About the Authors

E. A. Narodova
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia
Russian Federation
1, Partisan Zheleznyak St., Krasnoyarsk, 660022


A. A. Narodov
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia
Russian Federation
1, Partisan Zheleznyak St., Krasnoyarsk, 660022


N. A. Shnayder
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia V.M. Bekhterev National Medical Research Center, of Psychiatry and Neurology, Ministry of Health of Russia
Russian Federation

1, Partisan Zheleznyak St., Krasnoyarsk, 660022

3, Bekhterev St., Saint Petersburg 192019



D. V. Dmitrenko
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia
Russian Federation
1, Partisan Zheleznyak St., Krasnoyarsk, 660022


I. G. Strotskaya
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia
Russian Federation
1, Partisan Zheleznyak St., Krasnoyarsk, 660022


References

1. Карлов ВА, Гехт АБ, Гузева ВИ и др. Алгоритмы моно- и политерапии в клинической эпилептологии. Часть 1. Общие принципы выбора фармакотерапии. Журнал неврологии и психиатрии им. С.С. Корсакова. 2016;116(6):109-14 [Karlov VA, Guekht AB, Guzeva VI, et al. Algorithms of mono- and polytherapy in clinical epileptology. Part 1. General principles of drug choice. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova = S.S. Korsakov Neuroscience and Behavioral Physiology. 2016;116(6):109-14 (In Russ.)].

2. Карлов ВА. Эпилепсия у детей и взрослых женщин и мужчин. Москва: Медицина; 2010. 720 с. [Karlov VA. Epilepsiya u detey i vzroslykh zhenshchin i muzhchin [Epilepsy in children and adult women and men]. Moscow: Medicine; 2010. 720 p. (In Russ.)].

3. Мухин КЮ, Миронов МБ, Петрухин АС. Эпилептические синдромы. Диагностика и терапия. Москва: Системные решения; 2014. 376 c. [Mukhin KYu, Mironov MB, Petrukhin AS. Epilepticheskie sindromy. Diagnostika i terapiya [Epileptic syndromes. Diagnosis and therapy]. Moscow: System solutions; 2014. 376 p. (In Russ.)].

4. Карлов ВА, Авакян ГН, Калинин ВВ и др. «Псевдофармакорезистентность эпилепсии – современное состояние. Проблемы и пути решения». Проект заключения Совета экспертов (17 июня 2014 г.). Эпилепсия и пароксизмальные состояния. 2014;6(4):29- 30 [Karlov VA, Avakyan GN, Kalinin VV, et al. "Pseudopharmacoresistance of epilepsy is a modern condition. Problems and solutions". Draft opinion of the Council of Experts (June 17, 2014). Epilepsiya i Paroksizmal'nye Sostoyaniya = Epilepsia and Paroxyzmal Conditions. 2014;6(4):29-30. (In Russ.)].

5. Крылов ВВ, Гусев ЕИ, Гехт АБ и др. История развития хирургического лечения эпилепсии в Российской Федерации. Журнал неврологии и психиатрии им. С.С. Корсакова. 2016;116(9-2):6-12 [Krylov VV, Gusev EI, Guekht AB, et al. The history of surgical

6. treatment of epilepsy in the Russian Federation. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2016;116(9-2):6-12 (In Russ.)]. doi: 10.17116/jnevro2016116926-12

7. Казарян АА, Меликян АГ, Архипова НА и др. Хирургическое лечение височной эпилепсии у детей. Украинский нейрохирургический журнал. 2010;(3):29 [Kazaryan AA, Melikyan AG, Arkhipova NA, et al. Surgical treatment of temporal epilepsy in children. Ukrainskiy Neyrokhirurgicheskiy Zhurnal = Ukrainian Neurosurgical Journal. 2010;(3):29 (In Russ.)].

8. Иманкулов СА. Различные аспекты лечения симптоматической эпилепсии (обзор литературы). Вестник КазНМУ. 2014;(2):92-8 [Imankulov SA. Different aspects of symptomatic epilepsy management (review of literature). Vestnik KazNMU. 2014;(2):92-8 (In Russ.)].

9. Smits A, Duffau H. Seizures and the Natural History of World Health Organization Grade II gliomas: a review. Neurosurgery. 2011 May;68(5):1326-33. doi: 10.1227/NEU.0b013e31820c3419

10. Kahlenberg CA, Fadul CE, Roberts DW, et al. Seizure prognosis of patients with lowgrade tumors. Seizure. 2012 Sep;21(7):540-5. doi: 10.1016/j.seizure.2012.05.014. Epub 2012 Jun 20.

11. You G, Sha ZY, Yan W, et al. Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of lowgrade gliomas: a clinicopathological study. Neuro Oncol. 2012 Feb;14(2):230-41. doi: 10.1093/neuonc/nor205. Epub 2011 Dec 19

12. Thom M, Toma A, An S, et al. One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature. J Neuropathol Exp Neurol. 2011 Oct;70(10):859- 78. doi: 10.1097/NEN.0b013e3182302475

13. Yordanova YN, Moritz-Gasser S, Duffau H. Awake surgery for WHO Grade II gliomas within «noneloquent» areas in the left dominant hemisphere: toward a «supratotal» resection. Clinical article. J Neurosurg. 2011 Aug;115(2):232-9. doi: 10.3171/2011.3.JNS101333. Epub 2011 May 6.

14. Blonski M, Taillandier L, Herbet G, et al. Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life. J Neurooncol. 2012 Jan;106(2):353-66. doi: 10.1007/s11060-011-0670-x. Epub 2011 Jul 22.

15. Ruda R, Trevisan E, Soffietti R. Lowgrade gliomas. Handb Clin Neurol. 2012;105:437-50. doi: 10.1016/B978-0-444-53502-3.00001-X

16. Englot DJ, Berger MS, Barbaro NM, et al. Factors associated with seizure freedom in the surgical resection of glioneuronal tumors. Epilepsia. 2012 Jan;53(1):51-7. doi: 10.1111/j.1528-1167.2011.03269.x. Epub 2011 Sep 20.

17. Ruda R, Bello L, Duffau H, et al. Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro Oncol. 2012 Sep 1;14 Suppl 4:iv55-iv64. doi: 10.1093/neuonc/nos199

18. Дмитренко ДВ, Шнайдер НА, Дыхно ЮА и др. Опыт ведения пациенток, страдающих онкогенной эпилепсией. Российский онкологический журнал. 2017;(6) [Dmitrenko DV, Shnayder NA, Dyhno YuA, et al. Experience in managing patients with oncogenic epilepsy. Rossiyskiy Onkologicheskiy Zhurnal = Russian Cancer Journal. 2017;(6) (In Russ.)].

19. Chaichana KL, Pendleton C, Zaidi H, et al. Seizure control for patients undergoing meningioma surgery. World Neurosurg. 2013 Mar–Apr;79(3–4):515-24. doi: 10.1016/j.wneu.2012.02.051. Epub 2012 Mar 30.

20. Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014 Apr;55(4):475-82. doi: 10.1111/epi.12550. Epub 2014 Apr 14.

21. Pulman J, Greenhalgh J, Marson AG. Antiepileptic drugs as prophylaxis for post craniotomy seizures. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD007286. doi: 10.1002/14651858.CD007286.pub2

22. Zeng L, Wang L, Ye F, et al. Clinical characteristics of patients with asymptomatic intracranial meningiomas and results of their surgical management. Neurosurg Rev. 2015 Jul;38(3):481-8. doi: 10.1007/s10143-015-0619-1. Epub 2015 Feb 21.

23. Wirsching HG, Morel C, Gmü r C, et al. Predicting outcome of epilepsy after meningioma resection. Neuro Oncology. 2016 Jul;18(7):1002-10. doi: 10.1093/neuonc/nov303. Epub 2015 Dec 18.

24. Ghareeb F, Duffau H. Intractable epilepsy in paralimbic Word Health Organization Grade II gliomas: should the hippocampus be resected when not invaded by the tumor? J Neurosurg. 2012 Jun;116(6):1226-34. doi: 10.3171/2012.1.JNS112120

25. Калинин ВА, Громаковская МА. Мальформации коры головного мозга. Вторичные парциальные эпилепсии. Медицина и образование в Сибири. 2014;(6). URL: http://cyberleninka.ru/article/n/malformatsiikory-golovnogo-mozga-vtorichnye- partsialnyeepilepsii [Kalinin VA, Gromakovskaya MA. Malformation of cerebral cortex. Secondary partial epilepsies. Meditsina i Obrazovanie v Sibiri = Journal of Siberian Medical Sciences. 2014;(6). URL: http://cyberleninka.ru/article/n/malformatsii-kory-golovnogo- mozga-vtorichnye-partsialnye-epilepsii (In Russ.)].

26. Sarnat HB, Blumcke I. Malformations of cortical development. Surgical neuropathology of focal epilepsies: textbook and atlas. Paris: John Libbey Eurotext; 2015. P. 18-53.

27. Blü mcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia. 2011 Jan;52(1):158-74. doi: 10.1111/j.1528-1167.2010.02777.x. Epub 2010 Nov 10.

28. Айвазян СО. Фокальные корковые дисплазии: алгоритм предоперационного обследования. Эпилепсия и пароксизмальные состояния. 2012;4(2):6-12 [Ayvazyan SO. Focal cortical dysplasia: algorithm of preoperative examination. Epilepsiya i Paroksizmal'nye Sostoyaniya = Epilepsia and Paroxyzmal Conditions. 2012;4(2):6-12 (In Russ.)].

29. Гафуров БГ, Максудова ЛБ. Клинический анализ неврологических осложнений артеривенозных мальформаций головного мозга. Вестник КазНМУ. 2015;(2):347-8 [Gafurov BG, Maksudova LB. Clinical analysis of neurological complications of arteriovenous malformations of the brain. Vestnik KazNMU. 2015;(2):347-8 (In Russ.)].

30. Artyuhov IP, Dmitrenko DV, Shnayder NA, et al. New trends in management of epilepsy in patients with cerebral venous malformations: our experience. Int J Biomed. 2016 Sept 12;6(3):207-12. doi: 10.21103/Article6(3)_OA10

31. Jones BV, Linscott L, Koberlein G, et al. Increased prevalence of developmental venous anomalies in children with intracranial neoplasms. AJNR Am J Neuroradiol. 2015 Sep;36(9):1782-5. doi: 10.3174/ajnr.A4352. Epub 2015 May 28.

32. Shnayder NA, Dmitrenko DV, Sadykova AV, et al. Epidemiological studies on epilepsy in Siberia. Med Health Sci J. 2011;6(2):35-42. doi: 10.15208/mhsj.2010.105

33. Dmitrenko DV, Shnayder NA, Kiselev IA, et al. Problems of rational therapy for epilepsy during pregnancy. Open J Obstet Gynecol. 2014;4(9):506-15.

34. Scheidegger O, Wiest R, Jann K, et al. Epileptogenic developmental venous anomaly: insights from simultaneous EEG/fMRI. Clin EEG Neurosci. 2013;44:157-60. doi: 10.1177/1550059412464463. Epub 2013 Feb 7.

35. Griffiths D, Newey A, Faulder K, et al. Thrombosis of a developmental venous anomaly causing venous infarction and pontine hemorrhage. J Stroke Cerebrovasc Dis. 2013;22(8):e653-e655. doi: 10.1016/j.jstrokecerebrovasdis. 2013.04.033. Epub 2013 Jun 19

36. Meng G, Bai C, Yu T, et al. The association between cerebral developmental venous anomaly and concomitant cavernous malformation: an observational study using magnetic resonance imaging. BMC Neurol. 2014 Mar 15;14:50. doi: 10.1186/1471-2377-14-50

37. Копачев ДН, Шишкина ЛВ, Быченко ВГ и др. Склероз гиппокампа: патогенез, клиника, диагностика, лечение. Вопросы нейрохирургии им. Н.Н. Бурденко. 2016;80(4):109-16 [Kopachev DN, Shishkina LV, Bychenko VG, et al. Hippocampal sclerosis: pathogenesis, clinical features, diagnosis, and treatment. Voprosy Neyrokhirurgii im. N.N. Burdenko. 2016;80(4):109-16 (In Russ.)].

38. Blumcke I, Thom M, Aronica E, et al. International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a Task Force report from the ILAE Commission on Diagnostic Methods. Epilepsia. 2013 Jul;54(7):1315-29. doi: 10.1111/epi.12220. Epub 2013 May 20.

39. Engel J Jr, McDermott MP, Wiebe S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012 Mar 7;307(9):922-30. doi: 10.1001/jama.2012.220

40. Barba C, Rheims S, Minotti L, et al. Temporal plus epilepsy is a major determinant of temporal lobe surgery failures. Brain. 2016 Feb;139(Pt 2):444-51. doi: 10.1093/brain/awv372. Epub 2015 Dec 22.

41. Kwan P, Schachter SC, Brodie MJ. Drug-resistant epilepsy. N Engl J Med. 2011 Sep 8;365(10):919-26. doi: 10.1056/NEJMra1004418

42. Могилев АГ. Значение интраоперационного электрофизиологического мониторинга при выборе тактики нейрохирургического лечения симптоматической эпилепсии. Научные ведомости БелГУ. Серия: Медицина. Фармация. 2012;(10):159-66 [Mogilev AG. Value of intraoperative electrophysiological monitoring for choice tactics for neurosurgical treatment of symptomatic epilepsy. Nauchnye vedomosti BelGU. Seriya: Meditsina. Farmatsiya = Belgorod State University Scientific Bulletin. Medicine. Pharmacy. 2012;(10):159-66 (In Russ.)].

43. Georgiadis I, Kapsalaki EZ, Fountas KN. Temporal lobe resective surgery for medically intractable epilepsy: a review of complications and side effects. Epilepsy Res Treat. 2013;2013:752195. doi: 10.1155/2013/752195. Epub 2013 Oct 31.

44. Лебедев КЭ, Маматханов МР. Показания и общие принципы хирургического лечения эпилепсии (обзор). Нейрохирургия и неврология детского возраста. 2016; (2):66-78 [Lebedev KE, Mamatkhanov MR. Indications and general principles for surgical treatment of epilepsy (review). Neyrokhirurgiya i Nevrologiya Detskogo Vozrasta = Pediatric Neurology and Neurosurgery. 2016;(2):66-78 (In Russ.)].

45. Beier AD, Rutka JT. Hemispherectomy: historical review and recent technical advances. Neurosurg Focus. 2013;34(6):E11. doi: 10.3171/2013.3.FOCUS1341

46. Крылов ВВ, Гехт АБ, Трифонов ИС и др. Исходы хирургического лечения пациентов с фармакорезистентными формами эпилепсии. Журнал неврологии и психиатрии им. С.С. Корсакова. 2016;116(9-2):13-8 [Krylov VV, Guekht AB, Trifonov IS, et al. Outcomes of surgical treatment of patients with pharmacoresistant epilepsy. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova = Neuroscience and Behavioral Physiology. 2016;116(9-2):13-8 (In Russ.)].

47. Хачатрян ВА, Маматханов МР, Лебедев КЭ и др. Гемисферэктомия у детей старшего возраста (клиническое наблюдение). Нейрохирургия и неврология детского возраста. 2014;(1):72-83 [Khachatryan VA, Mamathanov MR, Lebedev KE, et al. Hemisperectomy in older children (case report). Neyrokhirurgiya i Nevrologiya Detskogo Vozrasta = Pediatric Neurology andNeurosurgery. 2014;(1):72-83 (In Russ.)].

48. Oliver A, Boling WW, Tanriverdi T. Techniques in epilepsy surgery: the MNI approach. New York: Camdrige University Press; 2012. 298 p.

49. Повереннова ИЕ, Кузнецова ТВ. Фармакорезистентные эпилепсии, ассоциированные с кортикальными дисплазиями. Неврология, нейропсихиатрия, психосоматика. 2013;5(1S):7-11 [Poverennova IE, Kuznetsova TV. Drug-resistant epilepsy associated with cortical dysplasias. Nevrologiya, Neyropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2013;5(1S):7- 11 (In Russ.)]. doi: 10.14412/2074-2711-2013-2481

50. Хачатрян ВА, Маматханов МР, Лебедев КЭ. Вагостимуляция в системе хирургического лечения эпилепсии (обзор литературы). Нейрохирургия и неврология детского возраста. 2012;(2-3):152-61 [Khachatryan VA, Mamathanov MR, Lebedev KE. Vagostimulation in the system of surgical treatment of epilepsy (literature review). Neyrokhirurgiya i Nevrologiya Detskogo Vozrasta = Pediatric Neurology and Neurosurgery. 2012;(2-3):152-61 (In Russ.)].

51. Morris GL 3rd, Gloss D, Buchhalter J, et al. Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013 Oct 15;81(16):1453-9. doi: 10.1212/WNL.0b013e3182a393d1. Epub 2013 Aug 28.

52. Morgan VL, Rogers BP, Abou-Khalil B. Segmentation of the thalamus based on BOLD frequencies affected in temporal lobe epilepsy. Epilepsia. 2015 Nov;56(11):1819-27. doi: 10.1111/epi.13186. Epub 2015 Sep 11.

53. Sweeney-Reed CM, Lee H, Rampp S, et al. Thalamic interictal epileptiform discharges in deep brain stimulated epilepsy patients. J Neurol. 2016 Oct;263(10):2120-6. doi: 10.1007/s00415-016-8246-5. Epub 2016 Aug 2.

54. Ситников АР, Григорян ЮА, Мишнякова ЛП. Двусторонняя радиочастотная передняя таламотомия у пациентов с фармакорезистентной эпилепсией. Вопросы нейрохирургии им. Н.Н. Бурденко. 2016;80(3):25-34 [Sitnikov AR, Grigoryan YuA, Mishnyakova LP. Bilateral radiofrequency anterior thalamotomy in intractable epilepsy patients. Voprosy Neyrokhirurgii im. N.N. Burdenko. 2016;80(3):25-34 (In Russ.)].

55. Cитников АР, Маслова НН, Григорян ЮА и др. Стереотаксическая деструкция и хроническая стимуляция передних таламических ядер для лечения фармакорезистентной эпилепсии. Вестник Смоленской государственной медицинской академии. 2017;16(1):135-43 [Sitnikov AR, Maslova NN, Grigoryan YuA, et al. Stereotactic lesion and chronic stimulation of anterior thalamic nuclei for treatment of pharmacoresistant epilepsy. Vestnik Smolenskoy Gosudarstvennoy Meditsinskoy Akademii = Vestnik of the Smolensk State Medical Academy. 2017;16(1):135-43 (In Russ.)].

56. Brodie MJ, Barry SJ, Bamagous GA, et al. Patterns of treatment response in newly diagnosed epilepsy. Neurology. 2012 May 15;78(20):1548-54. doi: 10.1212/WNL.0b013e3182563b19. Epub 2012 May 9.

57. Choi H, Hayat MJ, Zhang R, et al. Drugresistant epilepsy in adults: Outcome trajectories after failure of two medications. Epilepsy. 2016;57(7):1152-60. doi: 10.1111/epi.13406. Epub 2016 Jun 6.

58. Хачатрян ВА. Некоторые актуальные проблемы хирургии эпилепсии. Нейрохирургия и неврология детского возраста. 2016;(4):8-15 [Khachatryan WA. Some actual problems in epilepsy treatment. Neyrokhirurgiya i Nevrologiya Detskogo Vozrasta = Pediatric Neurology and Neurosurgery. 2016;(4):8-15. (In Russ.)].

59. Лебедева АВ, Меликян ЭГ, Степаненко АЮ и др. Динамика качества жизни у пациентов с фармакорезистентной эпилепсией при хирургических методах лечения. Вестник Национального медико-хирургического центра им. Н.И. Пирогова. 2011;6(3):67-70 [Lebedeva AV, Melikyan EG, Stepanenko AYu, et al. Quality of life dynamics in pharmacoresistent epilepsy patients after epilepsy surgery. Vestnik Natsional'nogo Mediko-Khirurgicheskogo Tsentra im. N.I. Pirogova = Bulletin of Pirogov National Medical & Surgical Center. 2011;6(3):67-70 (In Russ.)].


For citation:


Narodova E.A., Narodov A.A., Shnayder N.A., Dmitrenko D.V., Strotskaya I.G. Current approaches to neurosurgical treatment for drug-resistant focal epilepsy in adults. Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1S):81-88. (In Russ.) https://doi.org/10.14412/2074-2711-2018-1S-81-88

Views: 223


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)